logo

ZYBT

Zhengye
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

Key Stats

--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

About ZYBT

Zhengye Biotechnology Holding Limited

One of China's veterinary vaccine manufacturers

Pharmaceutical
03/24/2023
01/07/2025
NASDAQ Stock Exchange
299
12-31
Common stock
No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin City, Jilin Province, China
--
Zhengye Biotechnology Holdings Limited was incorporated in the Cayman Islands on March 24, 2023 under the Cayman Islands Companies Law. It is an exempted limited liability company with no significant business of its own and conducts business through its main subsidiaries registered in China. Jilin Zhengye Biological Products Co., Ltd. is located in Jilin City, Jilin Province, Jiangcheng City, Beiguo. The company's predecessor was Harbin Veterinary Biopharmaceutical Factory of the Ministry of Agriculture. It moved to Jilin City in 1970 and has a history of more than 50 years. In 2004, it was restructured from Jilin Province Biological Products Factory. Now it is a private joint-stock enterprise. It is controlled by Jilin Zhengye Group, a national-level agricultural industrialization leader. In 2016, it was successfully listed on the New Third Board. The company has 14 GMP production lines including cell suspension culture and genetic engineering vaccines. The products cover four types of animal vaccines for pigs, poultry, cattle and sheep, and pets, with 43 product numbers and more than 80 specifications. The animal laboratory center, which was put into use in October 2015, is the first batch in China and the largest intelligent animal experiment and testing platform in Northeast China.

Company Financials

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime